S. Schmitz

发表

Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance

Alexander V. Favorov, Daria A. Gaykalova, Genevieve L. Stein-O’Brien, 2018, Genome Medicine.

Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer

J. Machiels, S. Schmitz, B. Mlecnik, 2015, Oncotarget.

Window of opportunity studies: Do they fulfil our expectations?

J. Machiels, F. Duhoux, S. Schmitz, 2016, Cancer treatment reviews.

Defining the needs of patients with recurrent and/or metastatic head and neck cancer: an expert opinion.

S. Schmitz, L. Giacomelli, P. Bossi, 2020, Critical reviews in oncology/hematology.

Prognostic factors and assessment of staging systems for head and neck soft tissue sarcomas in adults.

V. Grégoire, J. Machiels, M. Hamoir, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Long-term outcome of surgical excision for treatment of cervicofacial granulomatous lymphadenitis in children

S. Schmitz, M. Hainaut, Quentin Neven, 2020, European Archives of Oto-Rhino-Laryngology.

The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease.

V. Grégoire, J. Machiels, B. Weynand, 2012, Oral oncology.

Perioperative Complications after Parotidectomy Using a Standardized Grading Scale Classification System

M. Hamoir, A. van Maanen, S. Schmitz, 2021, Surgeries.

Perioperative Complications After Parotidectomy using a Standardized Grading Scale Classification System. Impact on Hospitalization Stay.

M. Hamoir, A. van Maanen, S. Schmitz, 2020 .

Advances in the management of squamous cell carcinoma of the head and neck

V. Grégoire, J. Machiels, M. Hamoir, 2014, F1000prime reports.

The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma

E. Genden, M. Hamoir, W. Mendenhall, 2018, Cancers.

Systemic Treatments: Chemotherapy and Targeted Therapies

J. Machiels, S. Schmitz, 2017 .

A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab

E. Fertig, V. Badovinac, J. Bauman, 2019, Biomarker Research.

Preclinical Activity of Ribociclib in Squamous Cell Carcinoma of the Head and Neck

D. Vertommen, J. Machiels, P. Roger, 2020, Molecular Cancer Therapeutics.

Metabolic Imaging Using Hyperpolarized Pyruvate–Lactate Exchange Assesses Response or Resistance to the EGFR Inhibitor Cetuximab in Patient-Derived HNSCC Xenografts

J. Machiels, O. Feron, Patrice D Cani, 2019, Clinical Cancer Research.

Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy

J. Machiels, G. Berchem, A. van Maanen, 2015, The oncologist.

Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neck.

J. Machiels, N. Michoux, B. Weynand, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials.

J. Machiels, L. De Cecco, M. Serafini, 2022, Oral oncology.

HER2 and HER3 in HPV+ and HPV− HNSCC—Letter

J. Machiels, S. Schmitz, R. Galot, 2016, Clinical Cancer Research.

The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck

V. Grégoire, M. Hamoir, S. Schmitz, 2014, Current Treatment Options in Oncology.

Extended voice‐sparing surgery in selected pyriform sinus carcinoma: Techniques and outcomes

M. Hamoir, S. Schmitz, B. Lengelé, 2012, Head & neck.

Emergency Percutaneous Tracheotomy

M. Hamoir, S. Schmitz, 2016 .

Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations

R. Helaers, M. Vikkula, S. Schmitz, 2021, Orphanet Journal of Rare Diseases.

Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study

M. Vikkula, E. Seront, S. Schmitz, 2018, Orphanet Journal of Rare Diseases.

Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.

J. Machiels, C. Corbet, S. Schmitz, 2022, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck

J. Machiels, S. Schmitz, 2016, Current Treatment Options in Oncology.

Schwannoma-like pleomorphic adenoma of the parotid

B. Weynand, M. Hamoir, H. Reychler, 2011, Rare tumors.

Vaccine-Based Immunotherapy for Head and Neck Cancers

J. Machiels, S. Schmitz, S. Beyaert, 2021, Cancers.

Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck

J. Machiels, Mariama El Baroudi, S. Schmitz, 2017, Cancer biology & therapy.

Molecular biology of squamous cell carcinoma of the head and neck: relevance and therapeutic implications

J. Machiels, S. Schmitz, 2010, Expert review of anticancer therapy.

Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck

J. Machiels, A. van Maanen, E. Seront, 2019, Front. Oncol..

Radical neck dissection: is it still indicated?

K. Pitman, M. Hamoir, J. Medina, 2012, European Archives of Oto-Rhino-Laryngology.

Multidisciplinary Management of Hypopharyngeal Carcinoma

V. Grégoire, J. Machiels, M. Hamoir, 2011 .

Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance

Alexander V. Favorov, Daria A. Gaykalova, Ludmila V. Danilova, 2018, Genome Medicine.

Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma

V. Grégoire, J. Machiels, B. Weynand, 2009, European Archives of Oto-Rhino-Laryngology.

Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck

J. Machiels, N. Michoux, R. Lhommel, 2015, Radiology and oncology.

Blockage of EGFR Pathway for Anticancer Therapy in Squamous Cell Carcinoma of the Head and Neck

J. Machiels, S. Schmitz, 2017 .

Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directions.

J. Machiels, M. Hamoir, G. Wolf, 2014, Cancer treatment reviews.

Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck: GORTEC 2006-01.

J. Machiels, N. Michoux, S. Faivre, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling.

A. Ashworth, J. Blay, W. Bodmer, 2014, Cancer research.

An innovative approach to tracheotomy in patients with major obstruction of the upper airway.

M. Hamoir, S. Schmitz, M. Van Boven, 2014, American journal of otolaryngology.

Technical description of a modified jet ventilation injector for airway laser surgery in neonates and infants: retrospective analysis of 20 cases.

M. Hamoir, S. Schmitz, F. Veyckemans, 2016, Journal of clinical anesthesia.

Percutaneous Tracheotomy in Emergency Situation Setting

M. Hamoir, S. Schmitz, M. Boven, 2015 .

A simple technique for closure of persistent tracheoesophageal fistula after total laryngectomy

M. Hamoir, S. Schmitz, J. V. van Damme, 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

New advances in targeted therapies for squamous cell carcinoma of the head and neck

J. Machiels, S. Schmitz, 2011, Anti-cancer drugs.

Pitfalls in preoperative work-up of parotid gland tumours: 10-year series.

B. Weynand, M. Hamoir, E. Marbaix, 2013, B-ENT.

Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck

Jean-Pascal Machiels, J. Machiels, S. Schmitz, 2011, Expert review of anticancer therapy.

Prospective validation of an institutional treatment strategy for T1N0M0 glottic carcinoma.

V. Grégoire, M. Hamoir, A. van Maanen, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

2′-deoxy-2′-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck

V. Grégoire, J. Machiels, N. Michoux, 2018, Oncotarget.

Epidermal Growth Factor Receptor Inhibition in Squamous Cell Carcinoma of the Head and Neck.

J. Machiels, S. Schmitz, 2015, Hematology/oncology clinics of North America.

Salvage surgery in recurrent head and neck squamous cell carcinoma: Oncologic outcome and predictors of disease free survival.

M. Hamoir, S. Schmitz, B. Lengelé, 2017, Oral oncology.

Seeding of the percutaneous endoscopic gastrostomy site from head and neck carcinoma: Case report and review of the literature

J. Machiels, M. Hamoir, S. Schmitz, 2013, Head & neck.

Perspectives on window of opportunity trials in head and neck cancer: lessons from the EORTC 90111-24111-NOCI-HNCG study.

S. Schmitz, L. Locati, C. Caballero, 2018, European journal of cancer.

Squamous Cell Carcinoma of the Head and Neck

J. Machiels, E. Seront, S. Schmitz, 2019, International Manual of Oncology Practice.